Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment
- Christofides, E.A.
- Stankiewicz, A.
- Denham, D.
- Bellido, D.
- Franek, E.
- Nakhle, S.
- Łukaszewicz, M.
- Reed, J.
- Cózar-León, V.
- Kosch, C.
- Karaś, P.
- Fitz-Patrick, D.
- Handelsman, Y.
- Warren, M.
- Hollander, P.
- Huffman, D.
- Raskin, P.
- Oroszlán, T.
- Lillestol, M.
- Ovalle, F.
ISSN: 1934-2403, 1530-891X
Year of publication: 2024
Volume: 30
Issue: 9
Pages: 810-816
Type: Article